A first-in-man phase i and pharmacokinetic study on CHR-2797 (Tosedostat), an inhibitor of M1 aminopeptidases, in patients with advanced solid tumors.
Clin Cancer Res
; 15(15): 4978-85, 2009 Aug 01.
Article
en En
| MEDLINE
| ID: mdl-19638462
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Inhibidores Enzimáticos
/
Glicina
/
Aminopeptidasas
/
Ácidos Hidroxámicos
/
Neoplasias
Tipo de estudio:
Diagnostic_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2009
Tipo del documento:
Article